Home > Dáil Éireann debate. Question 1592 – Healthcare policy [MCAP] [57098/23].

[Oireachtas] Dáil Éireann debate. Question 1592 – Healthcare policy [MCAP] [57098/23]. (17 Jan 2024)

External website: https://www.oireachtas.ie/en/debates/question/2024...


1592. Deputy Bríd Smith asked the Minister for Health the number of ministerial licence applications and MCAP applications have been made by clinics (details supplied); what products are available from these clinics; which products are available under MCAP and covered for reimbursement; when the MCAP review report is expected; and if he will make a statement on the matter. [57098/23]

Stephen Donnelly, Minister for Health: The identity of clinicians who either apply for a Ministerial Licence or to enter the Cannabis for Medical Use Register for the purpose of treating their patients is confidential and will not be made public.

The products available to MCAP patients are defined as "specified controlled drugs" S.I. No. 262/2019 - Misuse Of Drugs (Prescription And Control Of Supply Of Cannabis For Medical Use) Regulations 2019, and are contained in Schedule 1 of the Regulations as set out below and are covered by the Long |Term Illness, GMS or Medical Card as appropriate.

Name of Cannabis product or preparation and brand name

Dosage form

Concentration of THC (percentage, weight/weight or weight/volume)

Name of manufacturer

Aurora High CBD Oil Drops

Oral solution

Less than 3% w/v (< 30mg/ml) This product also contains cannabidiol (CBD) 60% w/v (600mg/ml)

Aurora Cannabis Enterprises Inc., 4439 Township Road 304, Cremona, Alberta, Canada, T0M 0R0

CannEpil ™

Oral solution

0.5% w/v (5mg/ml) This product also contains cannabidiol (CBD) 10% w/v (100mg/ml)

MGC Pharmaceuticals d.o.o., Kamniška ulica 29, 1000, Ljubljana, Slovenia

Tilray Oral Solution THC10:CBD10 (25ml)

Oral solution

1% w/v (10mg/ml) This product also contains cannabidiol (CBD) 1% w/v (10mg/ml)

Tilray Portugal Unipessoal Lda., Zona Industrial de Cantanhede, Lote 121, Cantanhede, 3060-197, Portugal

Aurora Sedamen Softgels

Capsules

5mg/capsule This product also contains cannabidiol (CBD) less than 0.2mg/capsule

Aurora Cannabis Enterprises Inc. 4250 14th Avenue, Markham, Ontario, Canada L3R 0J3

Oleo Bedrobinol

Dried flower

13.5% w/w (135mg/g) This product also contains cannabidiol (CBD) less than 1.0% w/w (less than 10mg/g)

Bureau voor Medicinale Cannabis Postbus 16114 2500 BC DEN HAAG The Netherlands

Oleo Bedrocan

Dried flower

22% w/w (220mg/g) This product also contains cannabidiol (CBD) less than 1.0% w/w (less than 10mg/g)

Bureau voor Medicinale Cannabis Postbus 16114 2500 BC DEN HAAG The Netherlands

Althea CBD12:THC10 (50ml)

Oil

1% w/v THC (10mg/ml) This product also contains 1.25% w/v (12.5mg/ml) cannabidiol (CBD)

Tasmanian Alkaloids pty Ltd T/A Extractas Bioscience, Westbury, Tasmania, Australia 7303

Oleo Genetics 10:10

Oil (oral solution)

1% w/v (10mg/ml) This product also contains cannabidiol (CBD) 1% w/v (10mg/ml)

ADREX Pharma GmbH Firmungstrabe 4 56068 Koblenz Germany

Oleo Genetics 25:1

Oil (oral solution)

2.5% w/v (25mg/ml) This product also contains cannabidiol (CBD) <0.1% w/v (<1mg/ml)

ADREX Pharma GmbH Firmungstrabe 4 56068 Koblenz Germany

Althea THC20:CBD1 (50ml)

Oil

2% w/v THC (20mg/ml) This product also contains <0.1% w/v (<0.1mg/ml) cannabidiol (CBD)

Tasmanian Alkaloids pty Ltd T/A Extractas Bioscience, Westbury, Tasmania, Australia 7303

The MCAP review is anticipated to be completed in 2024

Item Type
Dail Debates
Publication Type
Irish-related
Drug Type
Cannabis, Prescription/Over the counter
Intervention Type
Policy
Date
17 January 2024
EndNote

Repository Staff Only: item control page